Table 1.

Patient demographics and their visual analogue scale pre- and postoperatively

	Control group	Steroid group
No. of patients	28	29
Gender (male vs female)	18 vs 11	25 vs 4
Average age (years ± SD)	30.14 ± 8.15	29.82 ± 7.16
Symptom duration (weeks ± SD)	5.57 ± 2.67	5.89 ± 2.54
Pre-op VAS (avg ± SD)	7.92 ± 0.44	7.77 ± 0.35
Post-op 2-week VAS (avg ± SD)	3.92 ± 0.26	2.96 ± 0.38
Post-op 1-month VAS (avg ± SD)	3.03 ± 0.17	2.54 ± 0.20
Post-op 3-month VAS (avg ± SD)	3.01 ± 0.14	2.90 ± 0.29
Post-op 6-month VAS (avg ± SD)	3.13 ± 0.15	3.12 ± 0.28
Post-op 1-year VAS (avg ± SD)	3.30 ± 0.20	3.37 ± 0.16
Final follow-up VAS (avg ± SD)	3.45 ± 0.18	3.4 ± 0.19
Follow-up (months ± SD)	31.35 ± 5.17	31.20 ± 3.18

Values are displayed with their standard deviations (SD) from average (avg)

VAS visual analogue scale